This company has been marked as potentially delisted and may not be actively trading. Intensity Therapeutics (INTS) Institutional Ownership Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsCompetitorsEarningsHeadlinesOwnershipShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Intensity Therapeutics (NASDAQ:INTS)CurrentInstitutional OwnershipPercentage3.74%Number ofInstitutional Buyers(last 12 months)6TotalInstitutional Inflows(last 12 months)$398.82KNumber ofInstitutional Sellers(last 12 months)4TotalInstitutional Outflows(last 12 months)$717.10K Get INTS Insider Trade Alerts Want to know when executives and insiders are buying or selling Intensity Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data INTS Institutional Buying and Selling by Quarter Intensity Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/15/2025Armistice Capital LLC872,547$1.72M0.0%-22.6%5.778% 5/8/2025Mesirow Financial Investment Management Inc.40,000$79K0.0%+100.0%0.265% 4/15/2025Sapient Capital LLC976,797$1.92M0.0%+3.6%6.469% 2/18/2025GTS Securities LLC19,030$34K0.0%-49.0%0.126% 2/17/2025Citadel Advisors LLC14,964$26K0.0%N/A0.099% 2/7/2025Mesirow Financial Investment Management Inc.20,000$35K0.0%-54.7%0.132% 2/3/2025Sigma Planning Corp54,837$97K0.0%+14.9%0.363% 1/29/2025Sapient Capital LLC942,841$1.66M0.0%-6.7%6.244% 11/16/2024Geode Capital Management LLC64,349$246K0.0%+35.1%0.467% 8/12/2024Blair William & Co. IL37,805$185K0.0%N/A0.276% 4/26/2024Mesirow Financial Investment Management Inc.44,177$230K0.0%N/A0.322% 4/23/2024Sapient Capital LLC1,012,069$5.26M0.1%+406.0%7.382% 2/9/2024Hohimer Wealth Management LLC44,779$384K0.1%-76.0%0.327% 2/6/2024Sapient Capital LLC200,000$1.71M0.0%N/A1.459% 2/1/2024Sigma Planning Corp34,443$295K0.0%-28.5%0.251% 1/29/2024Sapient Capital LLC200,000$1.71M0.1%N/A1.459% 11/21/2023Hohimer Wealth Management LLC186,464$740K0.2%N/A1.360% 11/6/2023Sigma Planning Corp48,144$191K0.0%N/A0.352% (Data available from 1/1/2016 forward) INTS Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of INTS shares? During the previous two years, 9 institutional investors and hedge funds held shares of Intensity Therapeutics. The most heavily invested institutionals were Sapient Capital LLC ($1.92M), Armistice Capital LLC ($1.72M), Hohimer Wealth Management LLC ($384K), Geode Capital Management LLC ($246K), Blair William & Co. IL ($185K), Sigma Planning Corp ($97K), and Mesirow Financial Investment Management Inc. ($79K).Learn more on Intensity Therapeutics' institutional investors. What percentage of Intensity Therapeutics' stock is owned by institutional investors? 3.74% of Intensity Therapeutics' stock is owned by institutional investors. Learn more on INTS's institutional investor holdings. Which institutional investors have been buying Intensity Therapeutics' stock? The following institutional investors have purchased Intensity Therapeutics' stock in the last 24 months: Sapient Capital LLC ($1.25M), Hohimer Wealth Management LLC ($186.46K), Mesirow Financial Investment Management Inc. ($64.18K), Sigma Planning Corp ($55.24K), Blair William & Co. IL ($37.81K), Geode Capital Management LLC ($16.73K), and Citadel Advisors LLC ($14.96K). How much institutional buying is happening at Intensity Therapeutics? Institutional investors have bought a total of 130,547 shares in the last 24 months. This purchase volume represents approximately $398.82K in transactions. Which of Intensity Therapeutics' major shareholders have been selling company stock? The following institutional investors have sold Intensity Therapeutics stock in the last 24 months: Armistice Capital LLC ($254.32K), Sapient Capital LLC ($67.91K), Mesirow Financial Investment Management Inc. ($24.18K), and GTS Securities LLC ($18.26K). How much institutional selling is happening at Intensity Therapeutics? Institutional investors have sold a total of 364,668 shares in the last 24 months. This volume of shares sold represents approximately $717.10K in transactions. Related Companies EYEN Institutional Ownership TPST Institutional Ownership KALA Institutional Ownership CCM Institutional Ownership GBIO Institutional Ownership CARA Institutional Ownership ALXO Institutional Ownership TENX Institutional Ownership CYTH Institutional Ownership DARE Institutional Ownership This page (NASDAQ:INTS) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Intensity Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Intensity Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.